Massimo Bertinaria

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 10

Top Topics

Nlrp Inflammasome

Top Venues

Molecules (Basel, Switzerland)

Oxidative medicine and cellular longevity

Antioxidants (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Elisabetta Marini, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi, Serena Marchiò, Sandra Kovachka, Francesca Spyrakis, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF V600E Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Elisabetta Marini, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi, Serena Marchiò, Sandra Kovachka, Francesca Spyrakis, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF V600E Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Elisabetta Marini, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi, Serena Marchiò, Sandra Kovachka, Francesca Spyrakis, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF V600E Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Elisabetta Marini, Marta Giorgis, Marta Leporati, Barbara Rolando, Konstantin Chegaev, Loretta Lazzarato, Massimo Bertinaria, Marco Vincenti, Antonella Di Stilo
Multitarget Antioxidant NO-Donor Organic Nitrates: A Novel Approach to Overcome Nitrates Tolerance, an Ex Vivo Study. Antioxidants (Basel, Switzerland) 11 (1) (2022)
Elisabetta Marini, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi, Serena Marchiò, Sandra Kovachka, Francesca Spyrakis, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF V600E Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Simone Gastaldi, Valentina Boscaro, Eleonora Gianquinto, Christina F Sandall, Marta Giorgis, Elisabetta Marini, Federica Blua, Margherita Gallicchio, Francesca Spyrakis, Justin A MacDonald, Massimo Bertinaria
Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor. Molecules (Basel, Switzerland) 26 (13) (2021)
Massimo Bertinaria
Inflammasome Inhibitors. Molecules (Basel, Switzerland) 26 (22) (2021)
Claudia Penna, Manuela Aragno, Alessia Sofia Cento, Saveria Femminò, Isabella Russo, Federica Dal Bello, Fausto Chiazza, Debora Collotta, Gustavo Ferreira Alves, Massimo Bertinaria, Elisa Zicola, Valentina Mercurio, Claudio Medana, Massimo Collino, Pasquale Pagliaro
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades. Oxidative medicine and cellular longevity 2020 (2020)
Mattia Cocco, Carolina Pellegrini, Helios Martínez-Banaclocha, Marta Giorgis, Elisabetta Marini, Annalisa Costale, Gianluca Miglio, Matteo Fornai, Luca Antonioli, Gloria López-Castejón, Ana Tapia-Abellán, Diego Angosto, Iva Hafner-Bratkovič, Luca Regazzoni, Corrado Blandizzi, Pablo Pelegrín, Massimo Bertinaria
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease. Journal of medicinal chemistry 60 (9) (2017)
Mattia Cocco, Gianluca Miglio, Marta Giorgis, Davide Garella, Elisabetta Marini, Annalisa Costale, Luca Regazzoni, Vistoli Giulio, Marica Orioli, Raïhane Massulaha-Ahmed, Isabelle Détraz-Durieux, Marine Groslambert, Bénédicte F Py, Massimo Bertinaria
Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors. ChemMedChem 11 (16) (2016)